Samir K Ballas; Franca B Barton; Myron A Waclawiw; Paul Swerdlow; James R Eckman; Charles H Pegelow; Mabel Koshy; Duane R Bonds Baseline QOL results were available on all 299 MSH patients ...

SAN DIEGO -- Treatment with hydroxyurea led to more hematologic dose-limiting toxicities (DLTs) compared with placebo in patients with hemoglobin SC, a milder form of sickle cell disease (SCD), a ...

Without a doubt, hydroxyurea (and other pharmaceuticals ... The World Coalition on Sickle Cell Disease, launched in 2023, is an excellent example of the type of collaboration that will be needed ...

designed to help manage Sickle Cell Disease (SCD). This new formulation is a breakthrough as it does not require ...

New gene therapies could transform sickle cell treatment forever. A future without pain crises or hospitalizations may finally be within reach.

Sickle cell disease (SCD) has been historically overlooked ... In my lifetime, we have seen the U.S. Food and Drug Administration approve hydroxyurea as the first-ever drug proven to effectively ...

Despite progress in healthcare services for individuals living with sickle cell disease (SCD) in Africa, substantial gaps remain in advanced treatments for SCD. To help address this burden, Tanzania ...

Sickle cell disease is a group of congenital red ... to relieve symptoms as well as antibiotics to treat infections, hydroxyurea—a bone marrow suppressive agent that decreases red blood cell ...

Once it’s diagnosed, sickle cell disease is managed with hydroxyurea, a medication that reduces the frequency of pain and the need for blood transfusions. Children younger than 5 also receive ...

Sickle Cell Disease is a genetic blood disorder that ... Control of SCD: Managing the underlying disease is essential. Treatments such as hydroxyurea, regular blood transfusions, and bone marrow ...